SMS Pharmaceuticals Limited (SMSPHARMA.BO)

INR 242.45

(2.08%)

Total Assets Summary of SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited's latest annual total assets in 2023 was 10.34 Billion INR , up 17.56% from previous year.
SMS Pharmaceuticals Limited's latest quarterly total assets in 2023 FY was 10.34 Billion INR , up 17.56% from previous quarter.
SMS Pharmaceuticals Limited reported annual total assets of 8.79 Billion INR in 2022, up 2.34% from previous year.
SMS Pharmaceuticals Limited reported annual total assets of 8.59 Billion INR in 2021, up 5.82% from previous year.
SMS Pharmaceuticals Limited reported quarterly total assets of - INR for 2023 Q3, down -100.0% from previous quarter.
SMS Pharmaceuticals Limited reported quarterly total assets of 9.77 Billion INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of SMS Pharmaceuticals Limited (2023 - 2004)

Historical Annual Total Assets of SMS Pharmaceuticals Limited (2023 - 2004)

Year	Total Assets	Total Assets Growth
2023	10.34 Billion INR	17.56%
2022	8.79 Billion INR	2.34%
2021	8.59 Billion INR	5.82%
2020	8.12 Billion INR	33.61%
2019	6.07 Billion INR	8.79%
2018	5.58 Billion INR	11.2%
2017	5.02 Billion INR	1.9%
2016	4.93 Billion INR	5.39%
2015	4.67 Billion INR	-13.54%
2014	5.41 Billion INR	6.27%
2013	5.09 Billion INR	8.05%
2012	4.71 Billion INR	-4.16%
2011	4.91 Billion INR	4.39%
2010	4.71 Billion INR	8.23%
2009	4.35 Billion INR	9.26%
2008	3.98 Billion INR	13.75%
2007	3.5 Billion INR	17.88%
2006	2.97 Billion INR	78.94%
2005	1.66 Billion INR	8.0%
2004	1.53 Billion INR	0.0%

Year	Total Assets	Total Assets Growth
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q2	9.77 Billion INR	0.0%
2023 FY	10.34 Billion INR	17.56%
2023 Q4	10.34 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	8.79 Billion INR	0.0%
2022 FY	8.79 Billion INR	2.34%
2022 Q1	- INR	-100.0%
2022 Q2	8.57 Billion INR	0.0%
2021 Q4	8.59 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 Q2	8.79 Billion INR	0.0%
2021 FY	8.59 Billion INR	5.82%
2020 Q2	6.9 Billion INR	0.0%
2020 FY	8.12 Billion INR	33.61%
2020 Q4	8.12 Billion INR	0.0%
2019 FY	6.07 Billion INR	8.79%
2019 Q2	5.69 Billion INR	0.0%
2019 Q4	6.07 Billion INR	0.0%
2018 FY	5.58 Billion INR	11.2%
2018 Q4	5.58 Billion INR	0.0%
2017 FY	5.02 Billion INR	1.9%
2016 Q2	7.12 Billion INR	0.0%
2016 FY	4.93 Billion INR	5.39%
2015 Q4	4.67 Billion INR	0.0%
2015 FY	4.67 Billion INR	-13.54%
2015 Q2	5.91 Billion INR	0.0%
2014 Q4	5.41 Billion INR	0.0%
2014 Q2	5.06 Billion INR	0.0%
2014 FY	5.41 Billion INR	6.27%
2013 Q4	5.09 Billion INR	0.0%
2013 FY	5.09 Billion INR	8.05%
2013 Q2	4.52 Billion INR	0.0%
2012 FY	4.71 Billion INR	-4.16%
2012 Q4	4.71 Billion INR	0.0%
2011 FY	4.91 Billion INR	4.39%
2011 Q4	4.91 Billion INR	0.0%
2010 FY	4.71 Billion INR	8.23%
2009 FY	4.35 Billion INR	9.26%
2008 FY	3.98 Billion INR	13.75%
2007 FY	3.5 Billion INR	17.88%
2006 FY	2.97 Billion INR	78.94%
2005 FY	1.66 Billion INR	8.0%
2004 FY	1.53 Billion INR	0.0%

Peer Total Assets Comparison of SMS Pharmaceuticals Limited

Name	Total Assets	Total Assets Difference
Abbott India Limited	51.93 Billion INR	80.089%
Cipla Limited	327.17 Billion INR	96.839%
Gland Pharma Limited	106.61 Billion INR	90.3%
GlaxoSmithKline Pharmaceuticals Limited	35.73 Billion INR	71.064%
Kopran Limited	7.43 Billion INR	-39.132%
Marksans Pharma Limited	26.8 Billion INR	61.428%
NGL Fine-Chem Limited	3.55 Billion INR	-190.855%
Pfizer Limited	42.28 Billion INR	75.546%
Sanofi India Limited	17.14 Billion INR	39.696%